Perioperative blood transfusion does not affect survival after operation for renal cell cancer.
We retrospectively studied the effect of perioperative blood transfusion in 208 transfused and 50 nontransfused patients operated on during a 12-year period for renal cell cancer. The 5-year renal cell cancer specific survival rate was 0.46 in the transfused patients versus 0.62 in the nontransfused patients. However, when differences in risk factors were accounted for by Cox regression analysis, perioperative blood transfusion was not a significant risk factor. The study does not support the hypothesis that blood transfusion promotes death after operation for renal cell cancer.